NeoGenomics
NEO
$17.41
Share price
-1.14%
Change (1 day)
43.29%
Change (1 year)
P/S ratio for NeoGenomics (NEO)
P/S ratio as of April 2023 (TTM): 4.46
According to NeoGenomics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.45988. At the end of 2022 the company had a P/S ratio of 2.18.
P/S ratio history for NeoGenomics from 2001 to 2022
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2022 | 2.18 | -74.86% |
| 2021 | 8.67 | -35.51% |
| 2020 | 13.5 | 79.41% |
| 2019 | 7.50 | 74.16% |
| 2018 | 4.30 | 56.25% |
| 2017 | 2.75 | -0.07% |
| 2016 | 2.76 | -53.89% |
| 2015 | 5.98 | 107.23% |
| 2014 | 2.89 | 7.85% |
| 2013 | 2.68 | 42.62% |
| 2012 | 1.88 | 34.75% |
| 2011 | 1.39 | -1.66% |
| 2010 | 1.42 | -25.22% |
| 2009 | 1.89 | 95.84% |
| 2008 | 0.9665 | -67.2% |
| 2007 | 2.95 | -52.99% |
| 2006 | 6.27 | 172.35% |
| 2005 | 2.30 | -76.15% |
| 2004 | 9.65 | 286.99% |
| 2003 | 2.49 | -93.5% |
| 2002 | 38.4 | -100% |
| 2001 | > 1000 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Quest Diagnostics
DGX | 1.59 | -64.26% | 🇺🇸 USA |
 LabCorp LH | 1.37 | -69.22% | 🇺🇸 USA |
 RadNet RDNT | 1.02 | -77.14% | 🇺🇸 USA |
 Psychemedics PMD | 1.15 | -74.24% | 🇺🇸 USA |
 Enzo Biochem ENZ | 1.54 | -65.54% | 🇺🇸 USA |